FDA Protects Drug Cartel

Why does the government want seniors on limited incomes to spend more for prescription drugs in the United States when costs are much lower in Canada?

Exclusive to American Free Press

By Julia Foster

The Food and Drug Administration (FDA) is trying to stop citizens from ordering their medications from Canada where prices are significantly lower.

One of the greatest problems facing the aging population in this country is the cost of medical treatment and prescription drugs. Many live on low incomes and, often, have to make the difficult choice between purchasing their medications and food.

As a result of the rising cost of medications in America, more and more seniors have been turning to Canada to get their prescriptions filled where prices for many drugs are much lower.

According to the web site Prescription Drugs from Canada—mooseexpress.com/save-money-on-prescriptions.html—100 tablets of the diabetes drug glucophage can cost as much as $70.95 in the United States. In Canada, the price is $20. The thyroid medication synthroid can run $57.55 in America and only $15.26 in Canada.

Increased reports of this happening prompted a response by the federal government.

The FDA office in New York recently sent a letter to Canadian pharmacist Michael Hunter in Windsor, Ontario, telling him to stop shipment of prescription drugs to customers in the United States.

The FDA claims that the drugs may be counterfeit. But a lot of these drugs come from the same manufacturers, said Hunter.

Canada has its own agency, the Health Protection Branch, which regulates drugs, said Hunter. Not only must the brand names meet certain qualifications but also their generic brands must meet the same qualifications. Hunter swill comply with the FDA’s request.